Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy. Bone Marrow Transplant 2023 Apr;58(4):443-445

Date

12/23/2022

Pubmed ID

36550200

DOI

10.1038/s41409-022-01905-1

Scopus ID

2-s2.0-85144572498 (requires institutional sign-in at Scopus site)   22 Citations

Author List

Al Hadidi S, Szabo A, Esselmann J, Hammons L, Hussain M, Ogunsesan Y, Thalambedu N, Khan F, Sethi J, Janardan A, Radhakrishnan SV, Thanendrarajan S, Schinke C, Dhakal B, Janz S, Chhabra S, D'Souza A, Zangari M, van Rhee F, Mohan M

Authors

Anita D'Souza MD Professor in the Medicine department at Medical College of Wisconsin
Binod Dhakal MBBS, MD Professor in the Medicine department at Medical College of Wisconsin
Siegfried Janz MD Professor in the Medicine department at Medical College of Wisconsin
Sabarinath Venniyil Radhakrishnan MD Assistant Professor in the Medicine department at Medical College of Wisconsin
Aniko Szabo PhD Professor in the Data Science Institute department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

B-Cell Maturation Antigen
Humans
Immunotherapy, Adoptive
Multiple Myeloma
Patients